Corcept Shares Rise More Than 45% in Six Months: Here's Why - Corcept Therapeutics ( NASDAQ:CORT ) , Bioventus ( NASDAQ:BVS )
Shares of Corcept Therapeutics Incorporated CORT have gained 46.2% in the past six months against the industry's decline of 2%. The company's sole-marketed drug, Korlym ( mifepristone ) , which is approved for treating Cushing's syndrome, has been performing well.
| Ticker |
Sentiment |
Impact |
|
CORT
|
Somewhat Bullish
|
28 %
|
|
BVS
|
Somewhat Bullish
|
28 %
|
|
ILMN
|
Somewhat Bullish
|
17 %
|
|
FULC
|
Neutral
|
23 %
|
